Living with hepatitis C and treatment: The personal experiences of patients

Journal of Clinical Nursing

Volumn 18, Issue 16, 2009, Pages 2282-2291

  Sgorbini, Myra ^a   O'Brien, Louise ^b   Jackson, Debra ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Chronic hepatitis C; Interferon; Nurses; Nursing; Phenomenology; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; COST OF ILLNESS; DRUG COMBINATION; FAMILY; HEALTH SERVICE; HEPATITIS C; HUMAN; MIDDLE AGED; NURSING METHODOLOGY RESEARCH; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SELF DISCLOSURE; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIVIRAL AGENTS; ATTITUDE TO HEALTH; COST OF ILLNESS; DRUG THERAPY, COMBINATION; FAMILY; HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MIDDLE AGED; NEW SOUTH WALES; NURSING METHODOLOGY RESEARCH; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; RIBAVIRIN; SELF DISCLOSURE; SOCIAL ISOLATION; STEREOTYPING;

EID: 68149132783     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2009.02806.x     Document Type: Article

References (37)

1. Aitken C, McCaw R, Jardine D, Bowden S, Higgs P, Nguyen O, Crofts N Mellard M (2004) Change in hepatitis C virus genotype in injecting drug users. Journal of Medical Virology 74, 543 545. (Pubitemid 39426094)
2. Altschuler J (1997) Working with Chronic Illness. Macmillan Press Ltd, Great Britain.
3. Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN Seeff LB (1997) Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: multicenter trial. Hepatology 26, 473 477. (Pubitemid 27328328)
4. Dolan M (1997) The Hepatitis C Handbook, 1st edn. Catalyst Press, London.
5. Dore G, Law MG, MacDonald M Kaldor J (2003) Epidemiology of hepatitis C virus infection in Australia. Journal of Clinical Virology 26, 171 184. (Pubitemid 36206602)
6. Dusheiko G (1997) Side effects of alpha interferon in chronic hepatitis C. Hepatology 26, 112 121.
7. Eriksson M Svedlund M (2006) The intruder: spouses' narratives about life with a chronically ill partner. Journal of Clinical Nursing, 15, 324 333.
8. Farrell GC Cossart Y (1999) Introducing hepatitis C. Journal of the Royal Australian College of General Practitioners 28, 4 7.
9. Gill ML, Atiq M, Sattar S Khokhar N (2005) Psychological implications of hepatitis C virus diagnosis. Journal of Gastroenterology and Hepatology 20, 1741 1744. (Pubitemid 43961082)
10. Hoofnagle JH Seeff LB (2006) Peginterferon and ribavirin for chronic hepatitis C. The New England Journal of Medicine 355, 2444 2451. (Pubitemid 44903748)
11. Hopwood M, Treloar C Redsull L (2006a) Experiences of Hepatitis C Treatment and its Management: What Some Patients and Health Professionals say (Monograph 4/2006). National Centre in HIV Social Research. The University of New South Wales, Sydney.
12. Hopwood M, Treloar C Bryant J (2006b) Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs: Education, Prevention & Policy 13, 61 75.
13. Katz A (1997) 'Mom, I have something to tell you'- disclosing HIV infection. Journal of Advanced Nursing 25, 139 143. (Pubitemid 127454781)
14. Keating GM Curran MP (2003) Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C. Drugs 63, 701 730. (Pubitemid 36408076)
15. Koch T Harrington A (1998) Reconceptualizing rigour: the case for reflexivity. Journal of Advanced Nursing 28, 882 890. (Pubitemid 128451630)
16. Korevaar D Sievert W (1999) Antiviral therapy for chronic hepatitis C. Journal of the Royal Australian College of General Practitioners 28, 40 45.
17. Larsen PD, Miller KA Ostrow FS (1998) Sexuality. In Chronic Illness Impact and Intervention (Morlof LI ed). Jones & Bartlett Publishers, Boston, pp. 299 323.
18. Law MG, Dore GJ, Bath N, Thompson S, Crofts N, Dolan K, Giles W, Gow P, Kaldor J, Loveday S, Powell E, Spenser J Wodak A (2003) Modelling hep C virus incidence, prevalence and long term sequelae in Australia. International Journal of Epidemiology 32, 717 724. (Pubitemid 37304628)
19. Luxon BA, Grace M, Brassard D Bordens R (2002) Pegylated interferons for the treatment of chronic hepatitis C infection. Clinical Therapeutics 24, 1363 1383. (Pubitemid 35176970)
20. Milne H Oberle K (2005) Enhancing rigor in qualitative description: a case study. Journal of Wound, Ostomy and Continence Nurses Society 32, 413 420.
21. Moloney MF (1997) Hermeneutic research doesn't take a PhD. Journal of Nursing Scholarship 29, 9.
22. Morton S Johnson D (1996) Children and HIV: Supporting Children and their Families. The Stationary Office Limited, Edinburgh.
23. Netuveli G, Wiggins RD, Hildon Z, Montgomery SM Blane D (2005) Functional limitation in long standing illness and quality of life: evidence from a national survey. British Medical Journal 331, 1382 1383. (Pubitemid 43773492)
24. O'Brien L (2003) Phenomenology. In Nursing Research: Methods, Critical Appraisal and Utilisation (Schneider Z Elliott D eds). Southwood Press, Australia, pp. 193 204.
25. Oon CJ (1999) Biological actions of interferons, serological responses and adverse effects of therapy. In Hepatitis B in the Asian-Pacific Region. Sarum Print Limited, Great Britain, pp. 139 154.
26. Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Longon I, Castera L Dhumeaux D (2004) Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology 126, 703 714. (Pubitemid 38298318)
27. Pritchard-Jones J (2000) Hepatitis C Manual for GPs and other Health Care Workers, 3rd edn. Central Sydney Area Health Service, New South Wales.
28. Purcell R (1997) The hepatitis C virus: overview. Hepatology 26, 11 14.
29. Rataj D, Krajewska-Kulak E, Jankowiak B, Van Damme-Ostapowicz K, Nowecki ZI, Rutkowski P Niczyporuk W (2005) Quality of life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients. Cancer Nursing 28, 172 178. (Pubitemid 40734535)
30. Richmond J, Dunning P Desmond P (2004) Hepatitis C: a medical and social diagnosis. Australian Nursing Journal 73, 1 3.
31. Schafer A, Scheurlen M, Felten M Kraus M (2005) Physician-patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients. European Journal of Gastroenterology and Hepatology 17, 1387 1394. (Pubitemid 41830462)
32. Shepard CW, Finelli L Alter MJ (2005) Global epidemiology of hepatitis C virus infection. The Lancet 5, 558 567. (Pubitemid 41196755)
33. Strader DB, Wright T, Thomas DL Seeff L (2004) ASSLD practice guideline: diagnosis, management and treatment of hepatitis C. Hepatology 39, 1147 1171.
34. Sypsa V, Touloumi G, Papatheodoridis GV, Tassopoulos NC, Ketikoglou I, Vafiadis I, Tsantoulas D, Akriviadis E, Koutsounas S Hatzakis A (2005) Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. Journal of Viral Hepatitis 12, 543 550. (Pubitemid 41224261)
35. Ward RP Kugelmas M (2005) Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C. American Family Physician 72, 655 662. (Pubitemid 41176774)
36. Zic I (2005) Peginterferon alpha / ribavirin combination therapy for the treatment of hepatitis C infection. Gastroenterology Nursing 28, 317 328.
37. Zickmund S, Ho EY, Masuda M, Ippolito L LaBrecque DR (2003) 'They treated me like a leper': stigmatisation and the quality of life of patients with hepatitis C. Journal of General Internal Medicine 18, 835 844. (Pubitemid 37281779)